Smith Amends ProtoKinetix Stake Filing

TL;DR

Clarence Smith updated his 13D filing for ProtoKinetix (PKTX) on 6/13/24. Ownership details changed.

AI Summary

Clarence E. Smith filed an amendment (No. 21) to Schedule 13D on June 13, 2024, regarding ProtoKinetix, Inc. The filing indicates a change in beneficial ownership of the company's common stock. Smith's address is listed as 1409 Peachtree Road, Dayton Beach, Florida 32114.

Why It Matters

This filing updates ownership information for ProtoKinetix, Inc., which could signal changes in control or investment strategy by a significant shareholder.

Risk Assessment

Risk Level: medium — Schedule 13D filings often indicate significant changes in a company's ownership structure, which can lead to volatility.

Key Players & Entities

• Clarence E. Smith (person) — Filing person and beneficial owner
• ProtoKinetix, Inc. (company) — Subject company
• June 13, 2024 (date) — Date of event requiring filing

FAQ

Key Financial Figures

• $0.0000053 — ame of Issuer) Common Stock, par value $0.0000053 per share (Title of Class of Securiti
• $0.01 — ivate placement at a price per share of $0.01. On June 14, 2024, Mr. Smith acquired

Filing Documents

• pktx_smith13da.htm (SC 13D/A) — 31KB
• 0001079973-24-000895.txt ( ) — 32KB

SECURITY AND ISSUER

ITEM 1. SECURITY AND ISSUER The principal executive offices of ProtoKinetix are presently located at 109 W. Main St., Dalton, Ohio 45618.

IDENTITY AND BACKGROUND

ITEM 2. IDENTITY AND BACKGROUND (c) Oil and gas industry entrepreneur. Mr. Smith’s primary occupation is President, Chief Executive Officer and Director of ProtoKinetix. ProtoKinetix’s principal address is 109 W. Main St., Dalton, Ohio 45618.

SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION

ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION On June 13, 2024, Mr. Smith acquired 3,400,000 shares of common stock of ProtoKinetix pursuant to a private placement at a price per share of $0.01. On June 14, 2024, Mr. Smith acquired 3,100,000 shares of common stock of ProtoKinetix pursuant to a private placement at a price per share of $0.01.

PURPOSE OF THE TRANSACTION

ITEM 4. PURPOSE OF THE TRANSACTION No change.

INTEREST IN SECURITIES OF THE ISSUER

ITEM 5. INTEREST IN SECURITIES OF THE ISSUER (a) Mr. Smith beneficially owns 115,987,093 shares of common stock of ProtoKinetix which amounts to approximately 29.49% of the total number of common shares currently outstanding, of which 68,214,444 are owned directly by Mr. Smith, or held in a brokerage account for his benefit, 13,572,649 shares are owned indirectly by Mr. Smith through his trusts, 1,850,000 are owned indirectly by Mr. Smith through his retirement account, and 32,350,000 shares are owned directly by Mr. Smith by virtue of holding options exercisable in accordance with Rule 13d-1. (b) Mr. Smith has sole voting and dispositive power over 115,987,093 shares of common stock of ProtoKinetix. (c) Please see Item 3 above for a description of securities transactions. (d) No other person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of common stock described herein, except as described in Item 6, below. (e) Not applicable.

CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS

ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO THE SECURITIES OF THE ISSUER. No change.

MATERIAL TO BE FILED AS EXHIBITS

ITEM 7. MATERIAL TO BE FILED AS EXHIBITS No change. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. June 17, 2024 /s/ Clarence E. Smith Clarence E. Smith, CEO & Director

View Full Filing

View this SC 13D/A filing on SEC EDGAR